Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Replicel Life Sciences Inc REPCF


Primary Symbol: V.RP

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:RP)

Canadian Investment Regulatory Organization Trade Resumption - RP

Canada NewsWire October 21, 2024

Canadian Investment Regulatory Organization Trading Halt - RP

Canada NewsWire May 8, 2024

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire November 28, 2023

RepliCel Provides Corporate Update

Accesswire November 28, 2022

RepliCel (TSXV:RP) extends warrant expiry

Caroline Egan  September 16, 2022

RepliCel Announces Material Patent Milestones in Key Markets

Accesswire August 4, 2022

DermaPrecise(TM) Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections

Accesswire August 2, 2022

RepliCel's Manufacturing Inspected by Japan's PMDA

Accesswire July 28, 2022

CORRECTION: Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing

Accesswire July 26, 2022
View More News ››

Opinion & Analysis (TSXV:RP)

Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner

Streetwise Reports October 18, 2018

Cell Therapy Company and Chinese Firm Sign Marketing Deal

Streetwise Reports July 16, 2018

Cell Therapy Firm Finalizing $5.1M Strategic Investment and Partnership with Chinese Company

Streetwise Reports May 9, 2018

Regenerative medicine company's China deal is 'dramatically transformational'

Streetwise Reports January 19, 2018

Japan is fertile ground for biotech deals

The Life Sciences Report October 4, 2017

String of positive trial results boosts RepliCel's profile

The Life Sciences Report April 13, 2017
View More Opinion ››

Bullboard Posts (TSXV:RP)

RE:RE:news

Fully diluted includes options and warrants which are not worth anything at the current price. Any gifts to the holders of these...
RPINVESTOR1 - 3 days ago

RE:RE:news

Why these moves?! Just start a Voting "AS and directors get all and minority shareholders loose their shares"?
MetzGER - 5 days ago

RE:news

Another step in the plan.  Convert preferred shares to  common shares which brings the shares issued on a fully diluted basis...
Ingiboy - 6 days ago

news

RepliCel Life Sciences Announces Intention to complete Preferred Share Conversion and Settlement of Dividends VANCOUVER, BC – November...
lscfa - 6 days ago

RE:RE:Meeting date Dec 30

AS and his gang have little to no interest in meeting with the shareholders.  Because Replicel is still a publicly traded company at...
Ingiboy - November 7, 2024

RE:Meeting date Dec 30

Wow. Great date to get lots of involvement from shareholders !!! GLTA
bluemoons20 - November 7, 2024
View more Bullboard ››

Western Metallica Resources Corp.

Western Metallica Resources Corp.

Western Metallica Resources Corp. is a Canada-based mineral exploration company with five mineral assets across Peru and ...
View More »